sinc
decemb
increas
number
coronaviru
case
report
around
globe
follow
outbreak
pandem
acut
respiratori
syndrom
coronaviru
infect
date
lack
specif
treatment
counteract
onset
sar
subsequ
multiorgan
failur
whose
evolut
usual
rapid
sever
liang
collabor
recent
describ
increas
risk
among
patient
cancer
also
associ
poorer
prognosi
thu
intern
panel
recommend
delay
suspend
anticanc
treatment
feasibl
rais
issu
potenti
cancer
progress
concern
oncogeneaddict
nonsmal
cell
lung
cancer
nsclc
patient
outcom
strongli
influenc
continu
administr
target
tyrosinekinas
inhibitor
tki
thu
withdraw
tki
might
detriment
subgroup
patient
becom
even
relev
pulmonari
infect
diagnos
accid
asymptomat
patient
herein
present
two
case
oncogenedriven
nsclc
patient
suspect
infect
maintain
target
therapi
tki
presenc
interstiti
pneumonia
recov
infect
without
specif
antivir
treatment
former
smoker
old
man
diagnos
alkrearrang
nsclc
januari
comput
tomographi
ct
scan
perform
late
decemb
document
tumor
lesion
right
hilum
right
lower
paratrach
lymphadenopathi
associ
bilater
lung
metastas
januari
patient
start
target
therapi
alectinib
advanc
diseas
march
patient
report
asthenia
dri
cough
absenc
fever
treat
beclometasoneformoterol
inhal
twice
daili
six
day
later
march
patient
develop
ageusia
anosmia
night
sweat
concomit
resolut
cough
symptom
resolv
march
requir
medic
ct
scan
perform
march
two
cycl
alectinib
show
partial
respons
diseas
collater
onset
slight
bilater
subpleur
groundglass
opac
fig
due
lack
symptom
patient
discharg
without
specif
medic
alectinib
continu
test
perform
rtpcr
april
result
neg
time
write
manuscript
patient
complet
asymptomat
continu
target
therapi
never
smoker
yearsold
man
diagnos
advanc
nsclc
septemb
patient
current
undergo
lorlatinib
novemb
follow
brain
progress
diseas
failur
previou
crizotinib
sinc
begin
treatment
well
toler
patient
achiev
metabol
complet
respons
thorac
diseas
decreas
brain
lesion
januari
still
document
last
radiolog
assess
perform
februari
march
patient
report
fever
c
dri
cough
worsen
subsequ
three
day
admiss
emerg
servic
highresolut
ct
hrct
scan
thorax
march
show
onset
multipl
bilater
ground
glass
opac
crazi
pave
pattern
fig
rtpcr
perform
march
neg
patient
treat
antibiot
treatment
azithromycin
ceftriaxon
day
sinc
march
lorlatinib
treatment
discontinu
six
day
begin
antibiot
therapi
symptom
improv
patient
wean
complet
oxygen
suppli
creactiv
protein
valu
high
time
admiss
hospit
mgl
normal
march
mgl
due
remiss
symptom
patient
discharg
march
new
ct
scan
perform
april
show
complet
resolut
interstiti
pneumonia
fig
knowledg
first
report
advanc
nsclc
patient
carri
target
therapi
tki
pneumonia
case
young
age
overal
good
perform
statu
two
import
factor
influenc
decis
continu
therapi
howev
note
sever
report
mild
patient
requir
antivir
hydroxi
chloroquin
case
neg
test
nasopharyng
swab
case
nevertheless
symptom
hrct
laboratori
find
highli
evoc
infect
case
test
perform
infect
remiss
henc
neg
result
specul
test
case
fals
neg
inde
neglig
rate
fals
neg
result
document
assess
rtpcr
consid
method
heavili
reli
presenc
viral
genom
site
sampl
collect
operatordepend
recent
paper
zhang
collabor
describ
case
egfrmut
nsclc
patient
continu
osimertinib
similarli
case
patient
slight
discomfort
infect
requir
intens
care
recov
pneumonia
follow
antivir
treatment
lopinavirritonavir
consid
interstiti
pneumonia
rare
albeit
potenti
sever
advers
event
patient
receiv
alktki
differenti
diagnosi
manifest
tkiinduc
side
effect
must
taken
account
sinc
radiolog
pattern
evoc
alway
diriment
multidisciplinari
discuss
radiologist
advis
subgroup
patient
ct
scan
find
must
necessarili
correl
clinic
laboratori
featur
even
though
outcom
patient
continu
tki
favor
could
draw
definit
conclus
larg
scale
studi
urgent
need
assess
whether
tki
maintain
pneumonia
especi
sever
order
avoid
potentiallydanger
withdraw
effect
anticanc
drug
francesco
facchinetti
declar
attend
editori
activ
sponsor
roch
bm
marcello
tiseo
declar
advisori
board
speaker
fee
astrazeneca
pfizer
eli
lilli
bm
novarti
roch
msd
boehring
ingelheim
otsuka
takeda
pierr
fabr
research
grant
astrazeneca
boehring
ingelheim
author
declar
conflict
interest
disclos
fig
ct
scan
case
lorlatinib
nsclc
perform
march
document
multipl
bilater
subpleur
groundglass
opac
crazi
pave
pattern
highli
suggest
pneumonia
b
ct
scan
recoveri
symptom
april
show
complet
resolut
interstiti
pneumonia
